Congenital Anomalies of the Gastrointestinal Tract Panel
Use
This test is designed for individuals with clinical or suspected diagnosis of congenital gastrointestinal tract anomalies. It is particularly useful for those presenting with gastrointestinal defects necessitating emergency neonatal surgery or as part of a suspected monogenic or chromosomal syndrome.
Special Instructions
This test is suitable for exome or genome analysis platforms. Additional options include exome-wide CNV analysis, prenatal testing, and STAT testing, providing adaptability based on the patient's condition and urgency.
Limitations
While this panel is comprehensive with 180 genes, the performance characteristics have not been cleared or approved by the US Food and Drug Administration. This analysis may not detect all genetic variations related to the congenital anomalies of the gastrointestinal tract.
New York Approved
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
7-16 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided